Eton Pharmaceuticals Inc. (ETON) Tops Q1 EPS by 4c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.07, $0.04 better than the analyst estimate of $0.03. Revenue for the quarter came in at $17.3 million versus the consensus estimate of $14.34 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Crude Inventory Rose 2.97 Million Barrels Last Week - EIA
• Stitch Fix (SFIX) call put ratio 4.9 calls to 1 put with a focus on October 2.5 and 5 calls into quarter results
• Costco (COST) call put ratio 1.5 calls to 1 put into quarter results